Report Detail

Pharmaceuticals & Healthcare Klaria Pharma Holding AB (KLAR) - Financial and Strategic SWOT Analysis Review

  • RnM1037814
  • |
  • 14 June, 2019
  • |
  • Global
  • |
  • 25 pages
  • |
  • GlobalData
  • |
  • Pharmaceuticals & Healthcare

Klaria Pharma Holding AB (KLAR) - Financial and Strategic SWOT Analysis Review

Table of Contents

    Section 1 - About the Company

      Klaria Pharma Holding AB - Key Information

        Klaria Pharma Holding AB - Overview

          Klaria Pharma Holding AB - Key Employees

            Klaria Pharma Holding AB - Key Employee Biographies

              Klaria Pharma Holding AB - Key Operational Heads

                Klaria Pharma Holding AB - Major Products and Services

                  Klaria Pharma Holding AB - History

                    Klaria Pharma Holding AB - Company Statement

                      Klaria Pharma Holding AB - Locations And Subsidiaries

                        Klaria Pharma Holding AB - Key Manufacturing facilities

                          Head Office

                            Other Locations & Subsidiaries

                              Section 2 - Company Analysis

                                Klaria Pharma Holding AB - Business Description

                                  Klaria Pharma Holding AB - Corporate Strategy

                                    Klaria Pharma Holding AB - SWOT Analysis

                                      SWOT Analysis - Overview

                                        Klaria Pharma Holding AB - Strengths

                                          Klaria Pharma Holding AB - Weaknesses

                                            Klaria Pharma Holding AB - Opportunities

                                              Klaria Pharma Holding AB - Threats

                                                Klaria Pharma Holding AB - Key Competitors

                                                  Section 3 - Company Financial Performance Charts

                                                    Klaria Pharma Holding AB - Financial Ratios

                                                      Financial Ratios - Capital Market Ratios

                                                        Financial Ratios - Annual Ratios

                                                          Financial Ratios - Interim Ratios

                                                            Financial Ratios - Ratio Charts

                                                              Section 4 - Appendix

                                                                Appendix

                                                                  Methodology

                                                                    Ratio Definitions

                                                                      About GlobalData

                                                                        Contact Us

                                                                          Disclaimer

                                                                            Note*: Some sections may be missing if data is unavailable for the company

                                                                            Summary

                                                                            Klaria Pharma Holding AB (Klaria Pharma) is a developer of fast acting medicinal products that designes, develops and commercializ therapeutics for migraine and cancer related pain. The company’s patented drug delivery platform is an alginate-based polymer film, facilitates quick and dependable transmucosal absorption of clinically established and marketed substances. It also offers reliable and stable supply forms than tablets and other delivery systems such as nasal sprays and orally dissolvable tablets. Klaria Pharma offers its products to customers globally through distributors. The company works in partnership with local pharmaceutical companies on clinical trials, registration, marketing, manufacturing, and others. Klaria Pharma is headquartered in Uppsala, Sweden.

                                                                            Klaria Pharma Holding AB Key Recent Developments

                                                                            May 23,2019: Klaria Pharma Holding announces quarterly report Q1 2019
                                                                            Mar 07,2019: Klaria submits cannabinoid formulation patent application following significant progress
                                                                            Oct 15,2018: Klaria Pharma Holding elects a new board member
                                                                            Aug 31,2018: Klaria announces management changes
                                                                            May 17,2018: Klaria starts the development of drugs with cannabinoids

                                                                            This comprehensive SWOT profile of Klaria Pharma Holding AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

                                                                            This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Klaria Pharma Holding AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

                                                                            The profile contains critical company information including*,

                                                                            - Business description – A detailed description of the company’s operations and business divisions.
                                                                            - Corporate strategy – Analyst’s summarization of the company’s business strategy.
                                                                            - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
                                                                            - Company history – Progression of key events associated with the company.
                                                                            - Major products and services – A list of major products, services and brands of the company.
                                                                            - Key competitors – A list of key competitors to the company.
                                                                            - Key employees – A list of the key executives of the company.
                                                                            - Executive biographies – A brief summary of the executives’ employment history.
                                                                            - Key operational heads – A list of personnel heading key departments/functions.
                                                                            - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
                                                                            - Key manufacturing facilities – A list of key manufacturing facilities of the company.
                                                                            - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
                                                                            - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

                                                                            Note*: Some sections may be missing if data is unavailable for the company.

                                                                            Key benefits of buying this profile include,

                                                                            You get detailed information about the company and its operations to identify potential customers and suppliers.
                                                                            - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

                                                                            Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
                                                                            - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

                                                                            Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
                                                                            - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

                                                                            Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
                                                                            - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

                                                                            Gain key insights into the company for academic or business research.
                                                                            - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.



                                                                            REPORT YOU MIGHT BE INTERESTED

                                                                            Purchase this Report

                                                                            $300.00
                                                                            $600.00
                                                                            $900.00
                                                                            235.77
                                                                            471.55
                                                                            707.32
                                                                            263.52
                                                                            527.05
                                                                            790.57
                                                                            32,151.00
                                                                            64,302.00
                                                                            96,453.00
                                                                            20,806.44
                                                                            41,612.88
                                                                            62,419.32
                                                                            Credit card Logo

                                                                            Related Reports


                                                                            Reason to Buy

                                                                            Request for Sample of this report